Review Paper: Cancer Chemopreventive Compounds and Canine Cancer
Open Access
- 9 March 2009
- journal article
- research article
- Published by SAGE Publications in Veterinary Pathology
- Vol. 46 (4) , 576-588
Abstract
Canine cancer has become more prevalent in recent years because of increased life expectancy and greater attention to the health of pets. The range of cancers seen in dogs is as diverse as that in human patients, and despite more intensive therapeutic interventions, fatality rates remain unacceptably high in both species. Chemoprevention is therefore an important means of confronting this disease. Because domestic pets share our environment, greater cross-application and study of the protumorigenic and antitumorigenic factors in our shared environment will benefit all species, leading to the development of new families of less toxic antitumorigenic compounds based on novel and established molecular targets. Currently, the most interesting cancer preventive agents are nonsteroidal anti-inflammatory drugs, peroxisome proliferator-activated receptor-γ ligands, and dietary compounds. This article provides an overview of what is known about how these agents affect molecular signaling in neoplastic disease, with reference to reported application and/or study in dogs where available.Keywords
This publication has 110 references indexed in Scilit:
- A Green Tea Component Suppresses Posttranslational Expression of Basic Fibroblast Growth Factor in Colorectal CancerGastroenterology, 2008
- Molecular characterisation of canine nonsteroidal anti-inflammatory drug-activated gene (NAG-1)The Veterinary Journal, 2008
- Multiple mechanisms are involved in 6‐gingerol‐induced cell growth arrest and apoptosis in human colorectal cancer cellsMolecular Carcinogenesis, 2007
- Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- Indole-3-carbinol and 3,3′-diindolylmethane induce expression of NAG-1 in a p53-independent mannerBiochemical and Biophysical Research Communications, 2005
- Cancer chemoprevention with dietary phytochemicalsNature Reviews Cancer, 2003
- PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancerTrends in Pharmacological Sciences, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- NSAID USE AND DECREASED RISK OF GASTROINTESTINAL CANCERSGastroenterology Clinics of North America, 1996